Like its peers, the impact of the present geopolitical situation may have curbed fiscal second-quarter profits for Medtronic.

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Luxembourg's Ministry of Health and Social Security has reported that a safety notice regarding certain models... }} ...

The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because of an increased risk of shorter battery life that could ...

Medtronic reports Q3 (fiscal Q2) earnings on 11/19. The revenue estimate is $8.28 billion, while the EPS GAAP estimate is $0.94. Investors should pay particular attention to how the MiniMed recall ...

Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

The FDA recently announced critical recalls on several widely used medical devices, including Life2000 ventilators, Medtronic's MiniMed insulin pumps and Boston Scientific's Obsidio conformable ...

Opens in a new tab or window A shorter-than-expected battery life prompted a voluntary recall of certain insulin pumps from Medtronic's MiniMed 600 and 700 series, the FDA detailed on Thursday.

Medtronic's MiniMed 670G - the closest thing yet to an artificial pancreas - has been launched in the US. The so-called 'hybrid closed-loop' system comprises a blood glucose sensor ...

Defensive industries, like healthcare, are more attractive to income investors. That's because companies in this sector are ...